IOVS Clinical Microbiology Reviews
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


(Investigative Ophthalmology and Visual Science. 2003;44:2565-2572.)
© 2003 by The Association for Research in Vision and Ophthalmology, Inc.
DOI:  10.1167/iovs.02-0913

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nicolela, M. T.
Right arrow Articles by LeBlanc, R. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nicolela, M. T.
Right arrow Articles by LeBlanc, R. P.

Effects of Cold-Induced Vasospasm in Glaucoma: The Role of Endothelin-1

Marcelo T. Nicolela, Suzanne N. Ferrier, Christine A. Morrison, Michele L. Archibald, Terry L. LeVatte, Karin Wallace, Balwantray C. Chauhan, and Raymond P. LeBlanc

From the Department of Ophthalmology, Dalhousie University, Halifax, Nova Scotia, Canada.

PURPOSE. Vasospasm has been associated with glaucoma, but its mechanisms have not been elucidated. The present study was designed to evaluate the role of endothelin (ET)-1, a potent endogenous vasoconstrictor, in the genesis of vasospasm in glaucoma.

METHODS. Our sample contained patients with open-angle glaucoma (n = 43) and subjects with normal nonglaucomatous eyes and without acral vasospasm (n = 27). After the eligibility visit, all subjects underwent a provocative cooling test, consisting of wearing for 30 minutes a head-vest cooling garment containing coolant fluid. Blood was collected before and after cooling, and plasma ET-1 was determined by immunoassay. In addition, visual fields and retinal blood flow, measured with a confocal scanning laser and Doppler flowmeter, were measured before and after cooling. Peripheral finger flow, skin temperature, and blood pressure were monitored during the experiment. A recovery visit was performed within 1 month, when visual field and retinal blood flow measurements were repeated.

RESULTS. Baseline plasma ET-1 levels were similar between patients with glaucoma and control subjects (mean ± SD: 2.81 ± 1.29 and 2.56 ± 1.36 pg/mL, respectively, P = 0.465). Patients with glaucoma, however, had a significant increase in plasma ET-1 after cooling (mean ± SD increase of 34% ± 52%, P = 0.001), not observed in control subjects (mean ± SD increase of 7% ± 43%, P = 0.750). No significant change in visual fields or retinal blood flow was observed after cooling in either group. Patients with glaucoma who had evidence of acral vasospasm, however, were more likely to show deterioration in visual fields after cooling than patients without acral vasospasm (P = 0.007).

CONCLUSIONS. Patients with glaucoma have an abnormal increase in plasma ET-1 after the body cools. It is possible that at least in some patients, increased levels of ET-1 in response to vasospastic stimuli may be involved in the pathogenesis of glaucomatous damage.





This article has been cited by other articles:


Home page
IOVSHome page
X. Wang, W. H. Baldridge, and B. C. Chauhan
Acute Endothelin-1 Application Induces Reversible Fast Axonal Transport Blockade in Adult Rat Optic Nerve
Invest. Ophthalmol. Vis. Sci., March 1, 2008; 49(3): 961 - 967.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
E. Henry, D. E. Newby, D. J. Webb, P. W. F. Hadoke, and C. J. O'Brien
Altered endothelin-1 vasoreactivity in patients with untreated normal-pressure glaucoma.
Invest. Ophthalmol. Vis. Sci., June 1, 2006; 47(6): 2528 - 2532.
[Abstract] [Full Text] [PDF]


Home page
Arch OphthalmolHome page
L. Wang, B. Fortune, G. Cull, J. Dong, and G. A. Cioffi
Endothelin B receptor in human glaucoma and experimentally induced optic nerve damage.
Arch Ophthalmol, May 1, 2006; 124(5): 717 - 724.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
A Y K Chan, D T L Liu, Y Allanore, A Kahan, and A Brezin
Increased prevalence of ocular glaucomatous abnormalities in systemic sclerosis * Authors' reply
Ann Rheum Dis, February 1, 2005; 64(2): 341 - 342.
[Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
M Emre, S Orgul, T Haufschild, S G Shaw, and J Flammer
Increased plasma endothelin-1 levels in patients with progressive open angle glaucoma
Br. J. Ophthalmol., January 1, 2005; 89(1): 60 - 63.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
D. Gherghel, S. L. Hosking, and I. A. Cunliffe
Abnormal Systemic and Ocular Vascular Response to Temperature Provocation in Primary Open-Angle Glaucoma Patients: A Case for Autonomic Failure?
Invest. Ophthalmol. Vis. Sci., October 1, 2004; 45(10): 3546 - 3554.
[Abstract] [Full Text] [PDF]


Home page
Arch OphthalmolHome page
G. A. Cioffi, L. Wang, B. Fortune, G. Cull, J. Dong, B. Bui, and E. M. Van Buskirk
Chronic Ischemia Induces Regional Axonal Damage in Experimental Primate Optic Neuropathy
Arch Ophthalmol, October 1, 2004; 122(10): 1517 - 1525.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
I Tomida, R G Pertwee, and A Azuara-Blanco
Cannabinoids and glaucoma
Br. J. Ophthalmol., May 1, 2004; 88(5): 708 - 713.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
A. M. McKendrick and D. R. Badcock
Decreased Visual Field Sensitivity Measured 1 Day, Then 1 Week, after Migraine
Invest. Ophthalmol. Vis. Sci., April 1, 2004; 45(4): 1061 - 1070.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
B. C. Chauhan, T. L. LeVatte, C. A. Jollimore, P. K. Yu, H. A. Reitsamer, M. E. M. Kelly, D.-Y. Yu, F. Tremblay, and M. L. Archibald
Model of Endothelin-1-Induced Chronic Optic Neuropathy in Rat
Invest. Ophthalmol. Vis. Sci., January 1, 2004; 45(1): 144 - 152.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the Association for Research in Vision and Ophthalmology